 Connection
Christopher Hoyte to Hallucinogens
This is a "connection" page, showing publications Christopher Hoyte has written about Hallucinogens.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.381 |
|
|
|
-
Simon MW, Olsen HA, Hoyte CO, Black JC, Reynolds KM, Dart RC, Monte AA. Clinical Effects of Psychedelic Substances Reported to United States Poison Centers: 2012 to 2022. Ann Emerg Med. 2024 Dec; 84(6):605-618.
Score: 0.197
-
Cohen N, Mathew M, Brent J, Wax P, Davis AL, Obilom C, Burns MM, Canning J, Baumgartner K, Koons AL, Wiegand TJ, Judge B, Hoyte C, Chenoweth JA, Froberg B, Farrar H, Carey JL, Hendrickson RG, Hodgman M, Caravati EM, Christian MR, Wolk BJ, Seifert SA, Bentur Y, Levine M, Farrugia LA, Vearrier D, Minns AB, Kennedy JM, Kirschner RI, Aldy K, Schuh S, Campleman S, Li S, Myran DT, Feng L, Freedman SB, Finkelstein Y. Severe outcomes following pediatric cannabis intoxication: a prospective cohort study of an international toxicology surveillance registry. Clin Toxicol (Phila). 2023 08; 61(8):591-598.
Score: 0.184
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|